Nuveen Asset Management, LLC Celldex Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 288,378 shares of CLDX stock, worth $7.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

288,378

Previous 363,635 20.7%

Holding current value

$7.72 Million

Previous $12.4 Million 41.01%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$23.31 - $32.4 $1.75 Million - $2.44 Million	-75,257 Reduced 20.7%	288,378 $7.29 Million
Q3 2024 Nov 14, 2024	SELL	$32.06 - $44.56 $2.19 Million - $3.04 Million	-68,245 Reduced 15.8%	363,635 $12.4 Million
Q2 2024 Aug 09, 2024	BUY	$32.76 - $42.56 $2.06 Million - $2.67 Million	62,797 Added 17.01%	431,880 $16 Million
Q1 2024 May 13, 2024	BUY	$35.22 - $51.88 $8.73 Million - $12.9 Million	247,888 Added 204.54%	369,083 $15.5 Million
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $20,688 - $37,194	915 Added 0.76%	121,195 $4.81 Million
Q3 2023 Nov 14, 2023	SELL	$25.45 - $37.46 $17,509 - $25,772	-688 Reduced 0.57%	120,280 $3.31 Million
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $12,721 - $16,077	420 Added 0.35%	120,968 $4.1 Million
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $343,000 - $467,754	-9,862 Reduced 7.56%	120,548 $4.34 Million
Q4 2022 Feb 14, 2023	SELL	$27.78 - $45.38 $534,376 - $872,929	-19,236 Reduced 12.85%	130,410 $5.81 Million
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $98,154 - $162,452	-4,324 Reduced 2.81%	149,646 $4.21 Million
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $410,902 - $748,242	20,044 Added 14.97%	153,970 $4.15 Million
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $94,888 - $134,985	-3,433 Reduced 2.5%	133,926 $4.55 Million
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $361,402 - $569,958	-10,129 Reduced 6.87%	137,359 $4.99 Million
Q3 2021 Nov 12, 2021	BUY	$28.95 - $55.99 $157,980 - $305,537	5,457 Added 3.84%	147,488 $8.02 Million
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $2.94 Million - $5.02 Million	142,031 New	142,031 $4.75 Million

Others Institutions Holding CLDX

# of Institutions

199

Shares Held

68.2M

Call Options Held

219K

Put Options Held

238K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.25B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Celldex Therapeutics, Inc. Transaction History